STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. MDCX
  4. [EFFECT] Medicus Pharma Ltd. SEC Filing

[EFFECT] Medicus Pharma Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 14, 2025 12:00 P.M.
Form: S-1
CIK: 0001997296
Company Name: Medicus Pharma Ltd.
File Number: 333-290586

Source: View Original Filing on SEC EDGAR

Stock MDCX logo
Medicus Pharma Ltd

NASDAQ:MDCX

MDCX Rankings

#5496 Ranked by Market Cap
N/A Ranked by Dividends

MDCX Latest News

Nov 17, 2025
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Nov 14, 2025
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Nov 13, 2025
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Oct 29, 2025
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
Oct 22, 2025
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

MDCX Latest SEC Filings

Nov 14, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 14, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 14, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 14, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 14, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)

MDCX Stock Data

47.20M
13.17M
35.91%
14.9%
1.87%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
Canada
W. CONSHOHOCKEN